His work has appeared in The New York Daily News and City & State. Volvo is continuing to drop hints about its upcoming high-tech electric sedan, the ES90, ahead of the EV’s official reveal next ...
COPENHAGEN, March 4 (Reuters) - Volvo Cars (VOLCARb.ST), opens new tab sold 50,662 cars in February, up 1% from a year earlier, the Sweden-based company said on Tuesday, as sales of its electric ...
A limited number of Volvo EX30 electric SUVs made it into Canada from the factory in Zhangjiakou, China where the car is assembled. Then tariffs on Chinese-made cars began, jeopardizing the future ...
Which is odd, because I did all of this to take a photo – well, alright, two photos – of a 1989 Volvo 760 saloon ... Those Volvos seemed so fussy and old-fashioned and uncool.
In partnership with Moderna MRNA, Merck is developing a personalized mRNA therapeutic cancer vaccine (V940/mRNA-4157) in combination with Keytruda for patients with certain types of melanoma and ...
Volvo, now, too is jumping into the fray with the 2026 Volvo ES90 electric fastback sedan to compete with Tesla even more directly on the back of a booming sales year helped by EV and hybrid sales.
It’s not unusual to hear someone talking about “growing up in the back of a Volvo estate” so it's hard ... “The V90’s boot is smaller in volume than the old V70’s, which I think ...
We have rated Volvo SUVs on a 10-point scale based on roughly 200 data points encompassing acceleration, handling, comfort, cargo space, fuel efficiency, value, and how enjoyable they are to drive.
The 2025 Volvo XC90 was launched in India with a price tag of ₹1.03 crore, ex-showroom. Unlike the outgoing model, the new one is only being offered in a single trim option - B5 Ultra. As expected ...
The Volvo ES90 won't just be a sedan version of the EX90 SUV. It'll come with a next-generation 800-volt architecture, which should make it a range and charging monster. Volvo says it'll charge ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...